Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 10021
    5. ›
  5. THE ROGOSIN INSTITUTE, INC.

THE ROGOSIN INSTITUTE, INC.

Company Details

Name: THE ROGOSIN INSTITUTE, INC.
Jurisdiction: New York
Legal type: DOMESTIC NOT-FOR-PROFIT CORPORATION
Status: Active
Date of registration: 15 Sep 1983 (42 years ago)
Entity Number: 867889
ZIP code: 10021
County: New York
Place of Formation: New York
Address: 505 EAST 70TH STREET, NEW YORK, NY, United States, 10021

Contact Details

Phone +1 212-312-5920

Phone +1 212-249-4970

Phone +1 212-746-1578

Phone +1 212-226-1177

Phone +1 646-317-0683

Phone +1 646-317-0420

Phone +1 718-457-3000

Phone +1 212-311-5000

Phone +1 347-783-7700

Phone +1 646-317-0493

Phone +1 646-317-0720

Phone +1 646-317-0394

Phone +1 718-830-3333

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 505 EAST 70TH STREET, NEW YORK, NY, United States, 10021

Unique Entity ID

A UEI is a government-provided number, like a tax ID number, that’s used to identify businesses eligible for federal grants, awards and contracts.

Note: In April 2022, the federal government replaced its old identifier of choice, the Data Universal Numbering System (DUNS) number, with a government-issued UEI. Now all the federal government’s Integrated Award Environment systems use UEI numbers instead of DUNS numbers. So any entity doing business with the federal government must register for a UEI.

Unique Entity ID:
RNFSMT79DVD4
CAGE Code:
5DRH0
UEI Expiration Date:
2025-09-23

Business Information

Activation Date:
2024-09-24
Initial Registration Date:
2009-03-31

Commercial and government entity program

The The Commercial And Government Entity Code (CAGE) is assigned by the Department of Defense's Defense Logistics Agency (DLA) and represents your company's physical address for GSA's mailings, payments, and administrative records.

Note: A CAGE Code enables a company to contract with the U.S. government, allowing bid on government contracts and to receive government payments. Also for business this means that it's a Verified business entity and Has a validated physical address.

CAGE number:
5DRH0
Status:
Active
Type:
Non-Manufacturer
CAGE Update Date:
2024-09-24
CAGE Expiration:
2029-09-24
SAM Expiration:
2025-09-23

Contact Information

POC:
BETTY-JANE SLOAN
Phone:
+1 646-317-0701
Fax:
+1 212-249-4659

National Provider Identifier

NPI Number:
1568208429
Certification Date:
2024-07-01
Link:
View on NPI website

Authorized Person:

Name:
ALLYSON ZALETTA PIFKO
Role:
CHIEF OPERATING OFFICER
Phone:
6463170698

Taxonomy:

Selected Taxonomy:
261QE0700X - End-Stage Renal Disease (ESRD) Treatment Clinic/Center
Is Primary:
Yes

Contacts:

Phone:
+1 646-317-0827
Phone:
+1 888-764-6746

Legal Entity Identifier

LEI Number:
5493000LR7AHHJFSBC55

Registration Details:

Initial Registration Date:
2016-07-09
Next Renewal Date:
2023-11-16
Registration Status:
LAPSED
Validation Source:
FULLY_CORROBORATED

Form 5500 Series

Employer Identification Number (EIN):
133184198
Plan Year:
2023
Number Of Participants:
65
Sponsors Telephone Number:
6463170694
File:
View File
Plan Year:
2022
Number Of Participants:
65
Sponsors Telephone Number:
6463170697
File:
View File
Plan Year:
2021
Number Of Participants:
64
Sponsors Telephone Number:
6463170697
File:
View File
Plan Year:
2020
Number Of Participants:
65
Sponsors Telephone Number:
6463170697
File:
View File
Plan Year:
2019
Number Of Participants:
64
Sponsors Telephone Number:
6463170694
File:
View File

History

Start date End date Type Value
1983-09-15 2006-03-23 Address THE ROGOSIN INSTITUTE, 429 EAST 71ST ST., NEW YORK, NY, 10021, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
140514000319 2014-05-14 CERTIFICATE OF MERGER 2014-05-14
060323000442 2006-03-23 CERTIFICATE OF CHANGE 2006-03-23
B109527-8 1984-06-07 CERTIFICATE OF AMENDMENT 1984-06-07
B020240-11 1983-09-15 CERTIFICATE OF INCORPORATION 1983-09-15

USAspending Awards / Contracts

Procurement Instrument Identifier:
36C24225N0161
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
224330.00
Base And Exercised Options Value:
224330.00
Base And All Options Value:
224330.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2024-12-01
Description:
IMMUNOGENETICS TESTING FOR THE RENAL TRANSPLANT PROGRAM
Naics Code:
621511: MEDICAL LABORATORIES
Product Or Service Code:
Q515: MEDICAL- PATHOLOGY
Procurement Instrument Identifier:
36C24224N0153
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
205305.00
Base And Exercised Options Value:
205305.00
Base And All Options Value:
205305.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2023-12-01
Description:
IMMUNOGENETICS TESTING FOR THE RENAL TRANSPLANT PROGRAM
Naics Code:
621511: MEDICAL LABORATORIES
Product Or Service Code:
Q515: MEDICAL- PATHOLOGY
Procurement Instrument Identifier:
36C24223N0265
Link:
View Award on USAspending website
Award Or Idv Flag:
AWARD
Award Type:
DELIVERY ORDER
Action Obligation:
201780.00
Base And Exercised Options Value:
201780.00
Base And All Options Value:
201780.00
Awarding Agency Name:
Department of Veterans Affairs
Performance Start Date:
2022-12-01
Description:
TISSUE TYPING FOR RENAL TRANSPLANT PATIENTS
Naics Code:
621511: MEDICAL LABORATORIES
Product Or Service Code:
Q515: MEDICAL- PATHOLOGY

USAspending Awards / Financial Assistance

Date:
2021-09-09
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
APPLICATION OF PROGENITOR NICHE SIGNALS TO EX VIVO NEPHROGENESIS - SPECIFIC AIMS THERE ARE MORE THAN 100K AMERICAN WAITING FOR A KIDNEY TRANSPLANT, BUT DEMAND FAR EXCEEDS SUPPLY. EX VIVO ORGANOGENESIS IS A POTENTIAL SOURCE FOR FUNCTIONAL TISSUE FOR RENAL REPLACEMENT THERAPY. WE AND OTHERS ESTABLISHED TECHNIQUES TO GENERATE CELLULARLY COMPLEX KIDNEY ORGANOIDS FROM HUMAN INDUCED PLURIPOTENT CELLS (IPSCS). THEORETICALLY, IPSC-DERIVED RENAL ORGANOIDS WOULD BE GRAFTED TO HOST TISSUE AND WOULD INTEGRATE WITH VASCULAR AND URINARY SYSTEMS TO SUPPLEMENT LOST KIDNEY FUNCTION. HOWEVER, DATA INDICATES THAT IMPLANTED ORGANOIDS INTEGRATE POORLY WITH THE HOST KIDNEY. BASED ON EXPERIMENTAL OBSERVATIONS, WE IDENTIFIED AT LEAST 3 KEY OBSTACLES THAT MUST BE OVERCOME TO GENERATE INTEGRATED RENAL ORGANOIDS (FIG. 1): TISSUE ORGANIZATION: ORGANOID TUBULES, BLOOD VESSELS, AND STROMA LACK CORTICO-MEDULLARY PATTERN. TUBULAR FUSION: WITH CURRENT STRATEGIES, ORGANOID TUBULES AND VESSELS DO NOT ANASTOMOSE WITH HOST TISSUES. FUNCTIONAL ASSAYS: WE LACK ASSAYS TO IDENTIFY SUCCESSFUL RENAL REPLACEMENT BY ORGANOID TISSUE. THE GOAL OF OUR COLLABORATIVE TEAM IS TO GENERATE THE TOOLS, REAGENTS AND PROTOCOLS TO OVERCOME EACH OF THESE OBSTACLES. IN OUR RECENT STUDIES, WE DISCOVERED THE FOLLOWING: 1) DISTINCT STROMAL CELL POPULATIONS ARE REQUIRED TO ESTABLISH CORRECT ZONAL ORGANIZATION AND SEGMENT-SPECIFIC DIFFERENTIATION OF TUBULES AND VASCULATURE; 2) ORGANOIDS LACK A NORMAL DISTRIBUTION AND COMPLEMENT OF STROMAL CELL POPULATIONS; 3) STROMAL CELLS AND THEIR SECRETED PRODUCTS CAN FACILITATE TUBULE-TUBULE INTERCONNECTION. THESE FINDINGS SHOW THAT FORMATION OF RENAL ORGANOIDS THAT ARE APPROPRIATELY PATTERNED FOR IN VIVO FUNCTION DEPENDS ON CREATING THE CORRECT COMPLEMENT AND ORGANIZATION OF STROMAL CELLS. THE CONCEPT THAT ANATOMICALLY “CORRECT” TISSUE THAT IS MATCHED TO THE ENGRAFTMENT SITE CAN BE GENERATED THROUGH MANIPULATION OF STROMAL CELL POPULATIONS IS NOVEL AND IDENTIFIES A GAP IN OUR UNDERSTANDING OF STROMAL CELL BIOLOGY OF DEVELOPING KIDNEY TISSUE. TO FILL THIS GAP AND GENERATE RESOURCES TO DETERMINE HOW THIS NOVEL PATTERNING MECHANISM CAN BE EXPLOITED TO GENERATE KIDNEY TISSUE FOR RENAL REPLACEMENT, WE PROPOSE A SERIES OF HYPOTHESIS-GENERATING INVESTIGATIONS THAT WILL DEFINE THE ROLES OF DIVERSE STROMAL CELLS IN PATTERNING THE VASCULATURE AND RENAL EPITHELIUM AS WELL AS PROMOTING TUBULAR CONNECTION TO THE HOST. OUR LONGTERM GOAL IS TO GENERATE FUNCTIONAL PROXIMAL NEPHRONS WITH APPROPRIATELY PATTERNED MICROVASCULATURE THAT INTEGRATE WITH THE HOST URINARY AND CIRCULATORY SYSTEMS FOR FUNCTIONAL RENAL REPLACEMENT. TO FACILITATE OUR EFFORTS TO PROMOTE TUBULE AND VASCULAR FUSION, WE WILL DEVELOP A PIPELINE FOR IN VIVO TESTING OF LABORATORY-DERIVED TISSUE IN ANIMALS WITH IMPAIRED KIDNEY FUNCTION. IN PRELIMINARY DATA, WE DEMONSTRATE NOVEL FUNCTIONAL ASSAYS INCLUDING ELISAS AND LIVE IMAGING OF TUBULAR FLUID FLOW THAT CAN RAPIDLY AND EASILY ASSESS THE CONTRIBUTION OF IMPLANTED ORGANOIDS TO HOST URINE PRODUCTION. WE WILL ALSO GENERATE NOVEL RESOURCES, INCLUDING STROMAL CELL LINES, REPORTER MICE, IMAGING TECHNOLOGY, AND ASSAYS TO QUANTIFY THE EXTENT OF RENAL REPLACEMENT BY ORGANOID TISSUE. WE PROPOSE THE FOLLOWING AIMS: AIM 1: DEVELOP STRATEGIES TO MODULATE ORGANOID STROMA TO PROMOTE PROXIMAL NEPHRON SEGMENTS 1A. DEVELOP PROTOCOLS TO PROMOTE FORMATION OF PROXIMAL TUBULE STROMA. 1B. INVESTIGATE THE ROLE OF MACROPHAGES IN ORGANOID DIFFERENTIATION. AIM 2. GENERATE ROBUST AND FUNCTIONALLY REGIONALIZED RENAL VASCULATURE IN TISSUE GRAFTS 2A. EVALUATE VASCULAR MAINTENANCE, GROWTH, AND RECRUITMENT IN ORGANOIDS. 2B. CHARACTERIZE STROMAL IMPACT ON ORGANOID VASCULATURE. 2C. GENERATE “VASCULAR-PRIMED” ORGANOIDS. AIM 3. IDENTIFY STRATEGIES TO PROMOTE TUBULE FUSION IN RENAL EPITHELIA 3A. IDENTIFY THE ROLE OF STROMAL INTERACTIONS ON EPITHELIAL TUBULE ANASTOMOSIS. 3B. DETERMINE THE ROLE OF HGF AND TGFSS ON TUBULE ANASTOMOSIS IN ORGANOIDS. AIM 4. EVALUATE FUNCTION OF GRAFT TISS
Obligated Amount:
6147162.21
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2019-09-13
Link:
View on USAspending
Awarding Agency Name:
Department of Health and Human Services
Transaction Description:
APPLICATION OF PROGENITOR NICHE SIGNALS TO EX VIVO NEPHROGENESIS
Obligated Amount:
7045081.75
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2023-01-05
Link:
View on USAspending
Awarding Agency Name:
Department of Defense
Transaction Description:
MODELING THE EFFECTS OF STROMA ON CLEAR CELL RENAL CELL CARCINOMA DE-OBLIGATE FUNDS TO CLOSE AWARD PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC), TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022. THIS MODIFICATION REFLECTS CHANGES CONSISTENT WITH THE TRANSFER TO DHA
Obligated Amount:
-801.91
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00
Date:
2020-03-04
Link:
View on USAspending
Awarding Agency Name:
Department of Defense
Transaction Description:
P00002 - EFFECTIVE 1 MARCH 2020 THIS AWARD IS HEREBY TRANSFERRED FROM MAINE HEALTH - MAINE MEDICAL CENTER 81 RESEARCH DRIVE SCARBOROUGH, ME 04074 7205 TO: ROGOSIN INSTITUTE 505 EAST 70TH STREET NEW YORK, NY 10021...EFFECTIVE 3/1/2020, SIGNED 3/4/2020, DISTRIBUTED 3/9/2020, FAADC 3/9/2020
Obligated Amount:
553824.00
Face Value Of Loan:
0.00
Total Face Value Of Loan:
0.00

OSHA's Inspections within Industry

Inspection Summary

Date:
2020-05-18
Type:
Fat/Cat
Address:
2372 LINDEN BOULEVARD, BROOKLYN, NY, 11208
Safety Health:
Health
Scope:
Partial

Tax Exempt

Employer Identification Number (EIN) :
13-3184198
In Care Of Name:
% GORDON FARLEY
Classification:
Literary Organization, Social Welfare Organization, Labor Organization, Chamber of Commerce, Mutual Cooperative Telephone Co.
Ruling Date:
2000-04
Deductibility:
Type of organization and use of contribution: A public charity. Deductibility Limitation: 50% (60% for cash contributions)

Related by officers

THE CORPORATION

ARSHIA DESIGNS INC. AAA VACUUM CORP. ATLANTICA TELECOM, INC. MISTY SPORTSWEAR, INC. FAT JAMS ELECTRONICS INC. CROQUEMBOUCHE, INC. LONG BEACH PEDIATRIC GROUP, P.C. LAW OFFICES OF JOSEPH A. GRECO, P.C. TEREZ, INC. 732 CINNAMON BEACH INC.

Related by address

505 EAST 70TH STREET, NEW YORK, NY, United States, 10021

ROGOSIN RESEARCH FOUNDATION, INC. ROGOSIN ASSAY DESIGNERS, LLC

Date of last update: 17 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated